| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/18/1999 | WO1999007693A1 Benzothiophenes |
| 02/18/1999 | CA2299309A1 Benzothiophenes |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 02/17/1999 | EP0896819A1 Antiglucocorticoid drug |
| 02/17/1999 | CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208413A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208412A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1207932A Menalgia plaster |
| 02/16/1999 | US5872114 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | WO1999006050A1 Remedial agent for baldness and other diseases |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298851A1 Remedial agent for baldness and other diseases |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207320A Calcium antagonist having parathyroid hormone secretion inhibition, preparing method and use thereof |
| 02/09/1999 | US5869537 Macrophage lipid chemoattractant |
| 02/03/1999 | EP0632794B1 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method |
| 02/03/1999 | CN1207131A Recombinant fusion proteins to growth hormone and serum albumin |
| 02/03/1999 | CN1207049A Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-'beta'-estradiol to the human organism |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/03/1999 | CN1041939C Androstenones |
| 02/02/1999 | US5866686 Nuclear thyroid hormone receptor-interacting polypeptides and related molecules and methods |
| 02/02/1999 | US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists. |
| 02/02/1999 | US5866160 Human therapy |
| 01/28/1999 | WO1999003876A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | WO1999003861A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | WO1999003476A1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 01/28/1999 | CA2296498A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | CA2294830A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892787A1 NOVEL $g(a)-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE |
| 01/27/1999 | CN1206422A Growth-hormone secretagogues |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0891188A1 Steroids as neurochemical initiators of change in human blood levels of lh or fsh |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205703A Polymorphic foams of growth hormone secretagogue |
| 01/20/1999 | CN1205689A Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, prepn. thereof and therapeutical use thereof |
| 01/19/1999 | US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency |
| 01/14/1999 | WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life |
| 01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | WO1999001116A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/14/1999 | WO1998042729A3 Steroid sulfamates, method for the production and use thereof |
| 01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | CA2295720A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/13/1999 | EP0889901A1 Process and intermediates for the synthesis of lhrh antagonists |
| 01/13/1999 | EP0889893A1 Azaspiroderivatives |
| 01/13/1999 | EP0889892A1 Azaspiro derivatives |
| 01/13/1999 | EP0889733A1 Stabilised growth hormone formulation and method of preparation thereof |
| 01/13/1999 | EP0889727A1 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 01/13/1999 | EP0847278A4 Analogs of parathyroid hormone |
| 01/13/1999 | CN1204518A Medicine for reducing pathologic raised beta-receptor and its producing tehcnology |
| 01/13/1999 | CN1041634C Oxytocin antagonist and compound and use thereof |
| 01/12/1999 | US5858394 Agent for transdermal administration that contains gestodene esters |
| 01/07/1999 | WO1999000353A1 Novel thyroid receptor ligands and method |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888358A1 Piperidine derivatives |
| 01/07/1999 | EP0888357A1 Azaspiro derivatives |
| 01/07/1999 | EP0724592B1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
| 01/07/1999 | EP0712412B1 15,15-dialkyl-substituted derivatives of estradiol |
| 01/07/1999 | DE19728517A1 TTS zur Verabreichung von Sexualsteroidhormonen TTS for the administration of sex steroids |
| 01/06/1999 | CN1204341A Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 01/05/1999 | US5856138 Human parathyroid hormone muteins and production thereof |
| 01/01/1999 | CA2236452A1 Gida1 |
| 12/30/1998 | WO1998058950A1 Compounds with growth hormone releasing properties |
| 12/30/1998 | WO1998058949A1 Treatment of insulin resistance with growth hormone secretagogues |
| 12/30/1998 | WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | EP0886645A1 New 19-nor-pregnene derivatives |
| 12/30/1998 | CA2294464A1 Treatment of insulin resistance |
| 12/29/1998 | US5854235 17-spiromethylene steroids |
| 12/29/1998 | US5854229 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 12/29/1998 | US5854211 Compounds with growth hormone releasing properties |
| 12/29/1998 | US5853748 Pharmaceutical compositions |
| 12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
| 12/29/1998 | CA2002859C Method of treating epithelial disorders |
| 12/29/1998 | CA1340291C Oxaspiro ¬2,5| octane derivative |
| 12/23/1998 | WO1998057919A1 Selective thyroid hormone analogs |
| 12/23/1998 | EP0885229A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 12/23/1998 | EP0885211A1 Compounds with a sulfamate group |
| 12/23/1998 | EP0885005A2 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men |
| 12/23/1998 | EP0719146B1 Novel method of progesterone delivery and effect thereof |
| 12/23/1998 | CN1202890A Amino acid derivatives, the preparation and use thereof as endothelia antagonists |
| 12/23/1998 | CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds |
| 12/23/1998 | CN1202882A New LH-RH antigonists with improved effectiveness |
| 12/23/1998 | CN1202823A Hydrolysis-optimized liplid emulsions and use thereof |
| 12/22/1998 | US5852058 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| 12/22/1998 | US5852002 Treatment of conditions and disease |
| 12/22/1998 | US5851992 Treatment of growth hormone deficiency |
| 12/17/1998 | WO1998056812A2 Estrogen receptor crystals and ligands |
| 12/17/1998 | WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 12/17/1998 | CA2292611A1 Estrogen receptor ligands |